Status: current, Defined. Date: 30-Jun 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 130461000168118 | Keyomega (arachidonic acid and docosahexaenoic acid with carbohydrate containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid) powder for oral liquid, 4 g sachet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 130471000168112 | Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 4 g sachet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 4 g sachet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 4 g sachet | Is a | Keyomega | true | Inferred relationship | Some | ||
| Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 4 g sachet | Is a | arachidonic acid and docosahexaenoic acid with carbohydrate containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 4 g sachet | true | Inferred relationship | Some | ||
| Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 4 g sachet | has manufactured dose form | powder for oral liquid | true | Inferred relationship | Some | ||
| Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 4 g sachet | has intended active ingredient | arachidonic acid and docosahexaenoic acid with carbohydrate | true | Inferred relationship | Some | 2 | |
| Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 4 g sachet | has unit of use | sachet | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 30 x 4 g sachets | has TPUU | True | Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 4 g sachet | Inferred relationship | Some | 1 |
| Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 30 x 4 g sachets | has TPUU | True | Keyomega containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 4 g sachet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR